Chicago Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Buy |
32,428
+1,930
| +6% | +$207K | 0.49% | 41 |
|
|
2025
Q1 | $3.08M | Sell |
30,498
-379
| -1% | -$38.2K | 0.55% | 41 |
|
|
2024
Q4 | $2.76M | Sell |
30,877
-339
| -1% | -$30.3K | 0.49% | 43 |
|
|
2024
Q3 | $2.62M | Buy |
31,216
+1,777
| +6% | +$149K | 0.45% | 54 |
|
|
2024
Q2 | $2.27M | Sell |
29,439
-128
| -0.4% | -$9.86K | 0.46% | 54 |
|
|
2024
Q1 | $2.03M | Sell |
29,567
-248
| -0.8% | -$17K | 0.42% | 67 |
|
|
2023
Q4 | $1.72M | Sell |
29,815
-598
| -2% | -$34.6K | 0.38% | 63 |
|
|
2023
Q3 | $1.61M | Buy |
30,413
+370
| +1% | +$19.5K | 0.4% | 61 |
|
|
2023
Q2 | $1.63M | Sell |
30,043
-210
| -0.7% | -$11.4K | 0.39% | 66 |
|
|
2023
Q1 | $1.51M | Sell |
30,253
-9,983
| -25% | -$499K | 0.38% | 71 |
|
|
2022
Q4 | $1.86M | Buy |
40,236
+595
| +2% | +$27.5K | 0.46% | 57 |
|
|
2022
Q3 | $1.54M | Sell |
39,641
-1,145
| -3% | -$44.3K | 0.4% | 66 |
|
|
2022
Q2 | $1.52M | Sell |
40,786
-1,325
| -3% | -$49.4K | 0.38% | 71 |
|
|
2022
Q1 | $1.87M | Sell |
42,111
-2,065
| -5% | -$91.5K | 0.4% | 69 |
|
|
2021
Q4 | $1.88M | Buy |
44,176
+10,511
| +31% | +$447K | 0.37% | 75 |
|
|
2021
Q3 | $1.46M | Buy |
33,665
+398
| +1% | +$17.3K | 0.32% | 86 |
|
|
2021
Q2 | $1.42M | Buy |
33,267
+6,239
| +23% | +$267K | 0.34% | 86 |
|
|
2021
Q1 | $1.04M | Buy |
27,028
+1,275
| +5% | +$49.2K | 0.36% | 79 |
|
|
2020
Q4 | $926K | Buy |
25,753
+778
| +3% | +$28K | 0.32% | 90 |
|
|
2020
Q3 | $954K | Buy |
24,975
+5,561
| +29% | +$212K | 0.4% | 77 |
|
|
2020
Q2 | $682K | Buy |
19,414
+2,948
| +18% | +$104K | 0.3% | 94 |
|
|
2020
Q1 | $537K | Buy |
16,466
+932
| +6% | +$30.4K | 0.27% | 96 |
|
|
2019
Q4 | $702K | Sell |
15,534
-70
| -0.4% | -$3.16K | 0.29% | 94 |
|
|
2019
Q3 | $635K | Buy |
+15,604
| New | +$635K | 0.27% | 97 |
|